Lobbying disclosures · Lobbying report
TEM: third_quarter 2026 lobbying report
Healthcare AI
Follow TEM- Became public
- Oct 20, 2026, 11:36 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 2:20 PM EST
Why this is connected
Exact legal-name match: Tempus AI, Inc. (https://www.sec.gov/Archives/edgar/data/1717115/).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/abcc4052-939b-42bd-93c3-f29b8691c0ee/","filing_uuid":"abcc4052-939b-42bd-93c3-f29b8691c0ee","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/abcc4052-939b-42bd-93c3-f29b8691c0ee/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt Mowers","dt_posted":"2026-10-20T11:36:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Avenue","registrant_address_2":"Suite 640","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401107294,"url":"https://lda.gov/api/v1/registrants/401107294/","house_registrant_id":55920,"name":"VALCOUR LLC","description":null,"address_1":"1455 Pennsylvania Avenue","address_2":"Suite 640","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MOWERS","contact_telephone":"+1 202-600-7791","dt_updated":"2026-07-21T14:32:19.518331-04:00"},"client":{"id":63887,"url":"https://lda.gov/api/v1/clients/63887/","client_id":63887,"name":"TEMPUS AI, INC.","general_description":"healthcare, AI","client_government_entity":null,"client_self_select":false,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Healthcare AI","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144619,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MOWERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151083,"prefix":"mr","prefix_display":"MR.","first_name":"WILLIAM","nickname":null,"middle_name":"KENNETH","last_name":"KILLION","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149886,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"CENTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in TEM
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Jan 23, 2026$50K–$100K
Rep. Nancy Pelosi (D-CA-11)
$50K–$100K · Traded Jan 16, 2026 · disclosed Jan 23, 2026 · Spouse
- Jun 9, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 9, 2025 · disclosed Jun 9, 2025
- Jan 17, 2025$50K–$100K
Rep. Nancy Pelosi (D-CA-11)
$50K–$100K · Traded Jan 14, 2025 · disclosed Jan 17, 2025 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.